LENDORMIN Side Effects

6100525-7 | Rash Scarlatiniform
on Feb 24, 2009 Female patient from JAPAN , weighting 113.3 lb, was diagnosed with insomnia, pruritus, reflux oesophagitis, cerebral infarction, shunt occlusion, renal failure chronic and was treated with Lendormin (View Usage). Patient experienced the following unwanted or unexpected effects: rash scarlatiniform. Lendormin dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ), TAKEPRON (View Takepron Review and Takepron Label ), PLAVIX (View Plavix Review and Plavix Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6080871-6 | Rash Scarlatiniform
Patient was taking Lendormin (View Usage). Patient had the following side effects: rash scarlatiniform on Feb 11, 2009 from JAPAN Additional patient health information: Female patient , weighting 113.3 lb, was diagnosed with pruritus, reflux oesophagitis, cerebral infarction, shunt occlusion, renal failure chronic and. Lendormin dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ), TAKEPRON (View Takepron Review and Takepron Label ), PLAVIX (View Plavix Review and Plavix Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6074214-1 | Anastomotic Complication, Hypoaesthesia, Hypoaesthesia Oral
Adverse event was reported on Jan 30, 2009 by a Male patient taking Lendormin (View Usage) (Dosage: ) was diagnosed with colon cancer recurrent and. Location: JAPAN , weighting 110.2 lb, After Lendormin was administered, patient had the following side effects: anastomotic complication, hypoaesthesia, hypoaesthesia oral. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), CALCIUM LEVOFOLINATE (300 Mg) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (625 Mg) (View Fluorouracil Review and Fluorouracil Label ), ELPLAT (130 Mg) (View Elplat Review and Elplat Label ).

5708008-0 | Dyskinesia
on Apr 04, 2008 Male patient from JAPAN , 77 years of age, was treated with Lendormin (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia. Lendormin dosage: 0.25 Mg. During the same period patient was treated with HALCION (0.25 Mg) (View Halcion Review and Halcion Label ), EVAMYL (2 Mg) (View Evamyl Review and Evamyl Label ), AMOBAN (7.5 Mg) (View Amoban Review and Amoban Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ).


5367601-8 | Interstitial Lung Disease
on Jun 12, 2007 Female patient from JAPAN , 46 years of age, was treated with Lendormin (View Usage). Patient had the following side effects: interstitial lung disease. Lendormin dosage: Unk. During the same period patient was treated with ZOLPIDEM (10 Mg) (View Zolpidem Review and Zolpidem Label ).

5115208-X | Fatigue, Suicide Attempt
Patient was taking Lendormin (View Usage). After Lendormin was administered, patient had the following side effects: fatigue, suicide attempt on Sep 20, 2006 from GERMANY Additional patient health information: Female patient , weighting 154.3 lb, . Lendormin dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4868277-6 | Hepatitis
Adverse event was reported on Nov 30, 2005 by a Female patient taking Lendormin (View Usage) (Dosage: ) . Location: JAPAN , 62 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). During the same period patient was treated with PEPCID RPD (View Pepcid Rpd Review and Pepcid Rpd Label ), BONZOL (View Bonzol Review and Bonzol Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), SENNOSIDES (View Sennosides Review and Sennosides Label ).

4811771-4 | Rhabdomyolysis
on Oct 21, 2005 Male patient from JAPAN , 50 years of age, was diagnosed with ill-defined disorder and was treated with Lendormin (View Usage). Patient had the following side effects: rhabdomyolysis. Lendormin dosage: Daily Dose: 1 Milligram(s). During the same period patient was treated with LUVOX (Daily Dose: 75 Milligram(s)) (View Luvox Review and Luvox Label ), DEPAS (Daily Dose: 1 Milligram(s)) (View Depas Review and Depas Label ).

4754119-6 | Erythema, Haematocrit Decreased, Lymphocyte Count Decreased, Lymphocyte Percentage Decreased, Monocyte Percentage Decreased, Platelet Count Decreased, Red Blood Cell Count Decreased, Skin Test Positive
on Jul 20, 2005 Male patient from JAPAN , 70 years of age, weighting 158.7 lb, was diagnosed with insomnia, sputum retention, hypertension, postoperative infection, bacterial sepsis, gastric disorder and was treated with Lendormin (View Usage). After Lendormin was administered, patient had the following side effects: erythema, haematocrit decreased, lymphocyte count decreased, lymphocyte percentage decreased, monocyte percentage decreased, platelet count decreased, red blood cell count decreased, skin test positive. Lendormin dosage: . During the same period patient was treated with BROMHEXINE HYDROCHLORIDE (View Bromhexine Hydrochloride Review and Bromhexine Hydrochloride Label ), NORVASC (View Norvasc Review and Norvasc Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), BIOFERMIN (View Biofermin Review and Biofermin Label ).

4564008-8 | Femoral Neck Fracture, Insomnia, Metastases To Bone, Metastases To Spine, Pain In Extremity
Patient was taking Lendormin (View Usage). Patient experienced the following unwanted or unexpected effects: femoral neck fracture, insomnia, metastases to bone, metastases to spine, pain in extremity on Dec 01, 2004 from Additional patient health information: Male patient , 73 years of age, weighting 154.3 lb, was diagnosed with insomnia, pain (What is pain?), polyuria, prostate cancer metastatic, gastric ulcer and. Lendormin dosage: . During the same period patient was treated with MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), LASIX (View Lasix Review and Lasix Label ), DECADRON (View Decadron Review and Decadron Label ), GASTER (View Gaster Review and Gaster Label ), CATLEP (View Catlep Review and Catlep Label ). Patient was hospitalized and became disabled.

4556430-0 | Abasia, Asthenia, Blood Creatinine Increased, Blood Urea Increased, Cerebrovascular Disorder, Epilepsy, Eye Movement Disorder, Oliguria, Pain
Adverse event was reported on Dec 22, 2003 by a Male patient taking Lendormin (View Usage) (Dosage: 3 Df/d) was diagnosed with nail tinea and. Location: , 74 years of age, Patient had the following side effects: abasia, asthenia, blood creatinine increased, blood urea increased, cerebrovascular disorder, epilepsy (What is epilepsy?), eye movement disorder, oliguria, pain (What is pain?). During the same period patient was treated with LOXONIN (3 Df/d) (View Loxonin Review and Loxonin Label ), ARTIST (20 Mg/d) (View Artist Review and Artist Label ), GASTER D (20 Mg/d) (View Gaster D Review and Gaster D Label ), ZYRTEC (1 Df, Qd) (View Zyrtec Review and Zyrtec Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ), EBASTEL (1 Df, Qd) (View Ebastel Review and Ebastel Label ), SIGMART (10 Mg/d) (View Sigmart Review and Sigmart Label ), MYONAL (150 Mg/d) (View Myonal Review and Myonal Label ). Patient was hospitalized.